Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC) Meeting Abstract


Authors: Dang, C. T.; Morris, P. G.; Patil, S.; Chen, C.; Abbruzzi, A.; Lehman, R.; Steingart, R.; Norton, L.; Hudis, C.
Abstract Title: Long-term cardiac safety and outcomes of dose-dense (dd) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) and trastuzumab (H) with and without lapatinib (L) in patients (pts) with early breast cancer (BC)
Meeting Title: 47th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 29
Issue: 15 Suppl.
Meeting Dates: 2011 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2011-05-20
Language: English
ACCESSION: WOS:000208880300082
DOI: 10.1200/jco.2011.29.15_suppl.579
PROVIDER: wos
Notes: Meeting Abstract: 579 -- Source: Wos
Altmetric Score
MSK Authors
  1. Sujata Patil
    386 Patil
  2. Patrick Glyn Morris
    107 Morris
  3. Clifford Hudis
    848 Hudis
  4. Larry Norton
    581 Norton
  5. Chau Dang
    161 Dang
  6. Richard M Steingart
    116 Steingart
  7. Carol Chen
    26 Chen
  8. Robert James Lehman
    9 Lehman